SEC Form 4 · accession 0001562180-17-001685
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paolo Pucci
Director
Period of report
May 2, 2017
Accepted (ET)
May 3, 2017 · 2:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 2, 2017 | A | 1,697 | $0.00 | A | 2,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitF2,F3 | — | holding | — | — | — | — | — | Common Stock | 56 | 56 | D |
Explanation of responses
- F1These shares of restricted stock units will vest in full after 8 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
- F3Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.